• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P物质对帕金森病大鼠苍白球神经元放电的影响。

Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats.

作者信息

Cui Qiao-Ling, Yung Wing-Ho, Chen Lei

机构信息

Department of Physiology, Faculty of Medicine, Qingdao University, Qingdao, 266071 Shandong, China.

出版信息

Neurosci Res. 2008 Feb;60(2):162-9. doi: 10.1016/j.neures.2007.10.007. Epub 2007 Oct 30.

DOI:10.1016/j.neures.2007.10.007
PMID:18054402
Abstract

Substance P is an important neurotransmitter or neuromodulator in central nervous system. Morphological studies have revealed the existence of substance P and its high affinity receptor, neurokinin-1 receptor, in globus pallidus. The expression of neurokinin-1 receptor in external globus pallidus has been reported to be decreased or unchanged in parkinsonian patients. To further investigate the effects of pallidal neurokinin-1 receptor in Parkinson's disease, an in vivo extracellular recording in 6-hydroxydopamine parkinsonian rats was performed. Micro-pressure ejection of selective neurokinin-1 receptor agonist, [Sar9,Met(O2)11] substance P (0.1mM), increased the spontaneous firing rate of pallidal neurons by 9.1% on the lesioned side, which was significantly weaker than that on the unlesioned side (20.7%), and that in normal rats (30.0%). The selective neurokinin-1 receptor antagonist, SR140333B, prevented the excitatory effects induced by [Sar9,Met(O2)11] substance P. Based on the action of substance P in globus pallidus of parkinsonian rats we hypothesize that the activity of neurokinin-1 receptors in globus pallidus may be decreased under parkinsonian state. This finding may provide a rationale for further investigations into the potential of pallidal substance P system in the treatment of Parkinson's disease.

摘要

P物质是中枢神经系统中一种重要的神经递质或神经调质。形态学研究已揭示苍白球中存在P物质及其高亲和力受体——神经激肽-1受体。据报道,帕金森病患者外侧苍白球中神经激肽-1受体的表达降低或未改变。为了进一步研究苍白球神经激肽-1受体在帕金森病中的作用,对6-羟基多巴胺帕金森病大鼠进行了体内细胞外记录。微量压力注射选择性神经激肽-1受体激动剂[Sar9,Met(O2)11]P物质(0.1mM),使损伤侧苍白球神经元的自发放电率增加了9.1%,明显弱于未损伤侧(20.7%)和正常大鼠(30.0%)。选择性神经激肽-1受体拮抗剂SR140333B可阻止[Sar9,Met(O2)11]P物质诱导的兴奋作用。基于P物质在帕金森病大鼠苍白球中的作用,我们推测帕金森病状态下苍白球中神经激肽-1受体的活性可能降低。这一发现可能为进一步研究苍白球P物质系统在帕金森病治疗中的潜力提供理论依据。

相似文献

1
Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats.P物质对帕金森病大鼠苍白球神经元放电的影响。
Neurosci Res. 2008 Feb;60(2):162-9. doi: 10.1016/j.neures.2007.10.007. Epub 2007 Oct 30.
2
Substance P excites globus pallidus neurons in vivo.P物质在体内可兴奋苍白球神经元。
Eur J Neurosci. 2007 Oct;26(7):1853-61. doi: 10.1111/j.1460-9568.2007.05803.x. Epub 2007 Sep 14.
3
Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats.神经降压素对6-羟基多巴胺损伤大鼠苍白球神经元的电生理效应
Neurosignals. 2009;17(2):153-61. doi: 10.1159/000199047. Epub 2009 Feb 7.
4
Modulation of the activity of globus pallidus by dopamine D1-like receptors in parkinsonian rats.帕金森病大鼠苍白球多巴胺 D1 样受体活性的调制。
Neuroscience. 2011 Oct 27;194:181-8. doi: 10.1016/j.neuroscience.2011.08.011. Epub 2011 Aug 6.
5
Behavioral and electrophysiological effects of 5-HT in globus pallidus of 6-hydroxydopamine lesioned rats.6-羟多巴胺损毁大鼠苍白球中 5-HT 的行为和电生理效应。
J Neurosci Res. 2010 May 15;88(7):1549-56. doi: 10.1002/jnr.22325.
6
Electrophysiological and behavioral effects of group III metabotropic glutamate receptors on pallidal neurons in normal and parkinsonian rats.正常和帕金森病大鼠苍白球神经元中 III 型代谢型谷氨酸受体的电生理和行为效应。
Synapse. 2013 Dec;67(12):831-8. doi: 10.1002/syn.21694. Epub 2013 Jul 27.
7
Behavioral and electrophysiological effects of pallidal GABAB receptor activation and blockade on haloperidol-induced akinesia in rats.苍白球GABAB受体激活和阻断对大鼠氟哌啶醇诱导的运动不能的行为和电生理影响。
Brain Res. 2008 Dec 9;1244:65-70. doi: 10.1016/j.brainres.2008.09.079. Epub 2008 Oct 9.
8
Different effects of dopamine D1 receptor on the firing of globus pallidus neurons in rats.多巴胺 D1 受体对大鼠苍白球神经元放电的不同影响。
Neurosci Lett. 2011 Jan 20;488(2):164-7. doi: 10.1016/j.neulet.2010.11.021. Epub 2010 Nov 13.
9
Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models.帕金森病早期和晚期实验模型中,苍白球诱发活动和静息活动的明显变化。
Eur J Neurosci. 2007 Sep;26(5):1267-79. doi: 10.1111/j.1460-9568.2007.05754.x.
10
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.NR2A和NR2B亚基选择性NMDA受体拮抗剂对纹状体苍白球神经元的不同作用:与帕金森病6-羟基多巴胺模型中运动反应的关系。
J Neurochem. 2008 Jul;106(2):957-68. doi: 10.1111/j.1471-4159.2008.05439.x. Epub 2008 Apr 24.

引用本文的文献

1
Pregabalin-associated movement disorders: A literature review.普瑞巴林相关的运动障碍:文献综述
Brain Circ. 2020 Jun 26;6(2):96-106. doi: 10.4103/bc.bc_57_19. eCollection 2020 Apr-Jun.
2
Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.纹状体神经递质在帕金森病和亨廷顿病发病机制中的新作用研究进展:综述。
Curr Neuropharmacol. 2019;17(2):165-175. doi: 10.2174/1570159X16666180302115032.
3
Pregabalin: a treatment option for dystonia?普瑞巴林:治疗肌张力障碍的一种选择?
Neurol Sci. 2012 Apr;33(2):351-4. doi: 10.1007/s10072-011-0737-7. Epub 2011 Aug 18.
4
The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.哺乳动物速激肽配体-受体系统:中枢神经系统疾病的新兴靶点。
CNS Neurol Disord Drug Targets. 2010 Nov;9(5):627-35. doi: 10.2174/187152710793361504.